障碍和促进药物警戒实践药师在马尼拉大都会,菲律宾。

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pharmacoepidemiology and Drug Safety Pub Date : 2024-12-01 DOI:10.1002/pds.70072
Rogie Royce Carandang, Justin Gabriel Gumop-As, Salve Regina Andoloy, Faye Louise Daguman, Leona Jenn Jose, Marielle Villarino, Peter Quilala
{"title":"障碍和促进药物警戒实践药师在马尼拉大都会,菲律宾。","authors":"Rogie Royce Carandang, Justin Gabriel Gumop-As, Salve Regina Andoloy, Faye Louise Daguman, Leona Jenn Jose, Marielle Villarino, Peter Quilala","doi":"10.1002/pds.70072","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The underreporting of adverse drug reactions (ADRs) remains a significant challenge in the Philippines. Pharmacists play a crucial role in ensuring medication safety, improving patient outcomes, and enhancing the overall effectiveness of pharmacovigilance (PV) systems. This study explored the barriers and facilitators affecting PV practices among pharmacists in Metro Manila.</p><p><strong>Methods: </strong>This study employed qualitative research through in-depth interviews using a semi-structured topic guide. Researchers interviewed pharmacists until data saturation was reached, where no new insights emerged. Qualitative data were analyzed inductively, utilizing Braun and Clarke's thematic analysis to identify key themes. MAXQDA was used to facilitate coding and analyzing the qualitative data.</p><p><strong>Results: </strong>A total of 40 pharmacists (72.5% female) participated in this study, evenly distributed across various practice areas and geographic locations in Metro Manila. The analysis identified four main themes related to pharmacists' nonreporting of ADRs: competency gaps, organizational challenges, reporting issues, and workplace constraints. Pharmacists' limited knowledge of ADRs and lack of experience in ADR reporting appear to be the primary barriers, along with environmental factors. Conversely, critical strategies for improving ADR notifications include capacity building, motivation and rewards, and work optimization.</p><p><strong>Conclusion: </strong>Pharmacists recognize the importance of reporting ADRs and view it as a professional responsibility. By prioritizing knowledge enhancement, training, and system improvements, the identification and reporting of ADRs can be strengthened, ultimately enhancing patient safety and PV practices. This positive attitude toward ADR reporting lays the groundwork for interventions designed to overcome barriers and promote a culture of active reporting among pharmacists.</p>","PeriodicalId":19782,"journal":{"name":"Pharmacoepidemiology and Drug Safety","volume":"33 12","pages":"e70072"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines.\",\"authors\":\"Rogie Royce Carandang, Justin Gabriel Gumop-As, Salve Regina Andoloy, Faye Louise Daguman, Leona Jenn Jose, Marielle Villarino, Peter Quilala\",\"doi\":\"10.1002/pds.70072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The underreporting of adverse drug reactions (ADRs) remains a significant challenge in the Philippines. Pharmacists play a crucial role in ensuring medication safety, improving patient outcomes, and enhancing the overall effectiveness of pharmacovigilance (PV) systems. This study explored the barriers and facilitators affecting PV practices among pharmacists in Metro Manila.</p><p><strong>Methods: </strong>This study employed qualitative research through in-depth interviews using a semi-structured topic guide. Researchers interviewed pharmacists until data saturation was reached, where no new insights emerged. Qualitative data were analyzed inductively, utilizing Braun and Clarke's thematic analysis to identify key themes. MAXQDA was used to facilitate coding and analyzing the qualitative data.</p><p><strong>Results: </strong>A total of 40 pharmacists (72.5% female) participated in this study, evenly distributed across various practice areas and geographic locations in Metro Manila. The analysis identified four main themes related to pharmacists' nonreporting of ADRs: competency gaps, organizational challenges, reporting issues, and workplace constraints. Pharmacists' limited knowledge of ADRs and lack of experience in ADR reporting appear to be the primary barriers, along with environmental factors. Conversely, critical strategies for improving ADR notifications include capacity building, motivation and rewards, and work optimization.</p><p><strong>Conclusion: </strong>Pharmacists recognize the importance of reporting ADRs and view it as a professional responsibility. By prioritizing knowledge enhancement, training, and system improvements, the identification and reporting of ADRs can be strengthened, ultimately enhancing patient safety and PV practices. This positive attitude toward ADR reporting lays the groundwork for interventions designed to overcome barriers and promote a culture of active reporting among pharmacists.</p>\",\"PeriodicalId\":19782,\"journal\":{\"name\":\"Pharmacoepidemiology and Drug Safety\",\"volume\":\"33 12\",\"pages\":\"e70072\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pds.70072\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology and Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pds.70072","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的:在菲律宾,药物不良反应(adr)的漏报仍然是一个重大挑战。药剂师在确保用药安全、改善患者预后和提高药物警戒(PV)系统的整体有效性方面发挥着至关重要的作用。本研究探讨了影响马尼拉大都会药剂师PV实践的障碍和促进因素。方法:本研究采用半结构化主题指南,通过深度访谈进行质性研究。研究人员采访了药剂师,直到数据饱和,没有新的见解出现。对定性数据进行归纳分析,利用Braun和Clarke的主题分析来确定关键主题。使用MAXQDA便于编码和分析定性数据。结果:共有40名药剂师(72.5%为女性)参与了本研究,平均分布在马尼拉大都会的各个执业区和地理位置。分析确定了与药剂师不报告adr相关的四个主要主题:能力差距、组织挑战、报告问题和工作场所限制。药师对不良反应的知识有限和缺乏不良反应报告经验似乎是主要障碍,此外还有环境因素。相反,改善ADR通知的关键策略包括能力建设、激励和奖励以及工作优化。结论:药师认识到报告不良反应的重要性,并将其视为一种职业责任。通过优先加强知识、培训和系统改进,可以加强对不良反应的识别和报告,最终提高患者安全和PV实践。这种对不良反应报告的积极态度为旨在克服障碍和促进药剂师积极报告文化的干预措施奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines.

Purpose: The underreporting of adverse drug reactions (ADRs) remains a significant challenge in the Philippines. Pharmacists play a crucial role in ensuring medication safety, improving patient outcomes, and enhancing the overall effectiveness of pharmacovigilance (PV) systems. This study explored the barriers and facilitators affecting PV practices among pharmacists in Metro Manila.

Methods: This study employed qualitative research through in-depth interviews using a semi-structured topic guide. Researchers interviewed pharmacists until data saturation was reached, where no new insights emerged. Qualitative data were analyzed inductively, utilizing Braun and Clarke's thematic analysis to identify key themes. MAXQDA was used to facilitate coding and analyzing the qualitative data.

Results: A total of 40 pharmacists (72.5% female) participated in this study, evenly distributed across various practice areas and geographic locations in Metro Manila. The analysis identified four main themes related to pharmacists' nonreporting of ADRs: competency gaps, organizational challenges, reporting issues, and workplace constraints. Pharmacists' limited knowledge of ADRs and lack of experience in ADR reporting appear to be the primary barriers, along with environmental factors. Conversely, critical strategies for improving ADR notifications include capacity building, motivation and rewards, and work optimization.

Conclusion: Pharmacists recognize the importance of reporting ADRs and view it as a professional responsibility. By prioritizing knowledge enhancement, training, and system improvements, the identification and reporting of ADRs can be strengthened, ultimately enhancing patient safety and PV practices. This positive attitude toward ADR reporting lays the groundwork for interventions designed to overcome barriers and promote a culture of active reporting among pharmacists.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
7.70%
发文量
173
审稿时长
3 months
期刊介绍: The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
期刊最新文献
Impact of Lookback Duration on the Performance of a Claims-Based Frailty Proxy in Women With Stage I-III Breast Cancer. Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom. Successful Linkage of Electronic Medical Records and National Health Data System in Type 2 Diabetes Research: Methodological Insights and Implications. Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis. Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1